Search

1222498
1230819
1201004
1195994
393884
ScimathUS
The South African Tuberculosis Vaccine Initiative will be offering a limited number of bursaries to cover the Registration Fees associated with the SciMathUS Program, a university preparation program which is offered by the Stellenbosch University...
2018 Tb under the Spotlight Science Engagement
The “TB Under the Spotlight Science Engagement” programme was conceptualised and presented by South African Tuberculosis Vaccine Initiative (SATVI) with scientists from the Division of Molecular Biology and Human Genetics at Stellenbosch University...
Community Engagement
Lienkie's Lungs TB Awareness Drama: SATVI collaborated with the UCT Drama Department and the Mothertongue Community project in developing "Lienkie se Longe", a drama to raise awareness about TB. The drama was performed at community clinics and...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
Carina's Choice: SATVI collaborated with UCT Drama Department and Worcester Secondary School in developing this play which was performed by learners from Worcester Secondary School at 8 local high schools reaching approximately 8 000 adolescents in...

News

Thursday, 24 January 2019
20 August 2018 Research Published: Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes

Associate Professor Tom Scriba has co-authored a research paper titled: "Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes" appearing in the Frontiers journal.

Publication Date:
Tue, 21 Aug 2018 - 11:15
17 August 2018 Research: Prospects for a vaccine to prevent HIV related Tuberculosis

SATVI Authors dr Elisa Nemes, Professor Mark Hatherill and Associate Professor Tom Scriba have published a paper titled: "Prospects for a vaccine to prevent HIV related Tuberculosis" appearing in the Current opinions in HIV/AIDS journal.

Publication Date:
Mon, 20 Aug 2018 - 15:45
Celebrating the legacy of Nelson Mandela

For this year’s Mandela Day the South African Tuberculosis Vaccine Initiative (SATVI) has announced its support for community based soup kitchens in the Cape Winelands District.

Publication Date:
Thu, 19 Jul 2018 - 12:45
Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies and hope for subunit vaccines.

Scientists from the South African Tuberculosis Vaccine Initiative (SATVI) and the Desmond Tutu HIV Foundation have announced publication in the New England Journal of Medicine of the results of an innovative clinical trial that provides encouraging new evidence that TB vaccines could prevent sustained TB infections in high-risk adolescents. our latest TB vaccine clinical trial have been published in the New England Journal of Medicine.

Publication Date:
Thu, 12 Jul 2018 - 08:15

Pages